{
    "Trade/Device Name(s)": [
        "Alinity i Toxo IgM",
        "Alinity i Toxo IgM Reagent Kit",
        "Alinity i Toxo IgM Calibrator",
        "Alinity i Toxo IgM Controls"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K233932",
    "Predicate Device Reference 510(k) Number(s)": [
        "k923166"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LGD"
    ],
    "Summary Letter Date": "December 13, 2023",
    "Summary Letter Received Date": "December 14, 2023",
    "Submission Date": "August 28, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3780"
    ],
    "Regulation Name(s)": [
        "Toxoplasma gondii serological reagents"
    ],
    "Analyte Class(es)": [
        "serology",
        "immunology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgM antibodies to Toxoplasma gondii"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Serum separator",
        "Plasma (lithium heparin)",
        "Plasma (lithium heparin separator)",
        "Plasma (tripotassium EDTA)"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator tube",
        "Lithium heparin plasma tube",
        "Lithium heparin plasma separator tube",
        "Tripotassium EDTA plasma tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Alinity i system"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Alinity i Toxo IgM assay for qualitative detection of IgM antibodies to Toxoplasma gondii using CMIA on the Alinity i system",
    "Indications for Use Summary": "Qualitative detection of IgM antibodies to Toxoplasma gondii in human serum and plasma as an aid in diagnosing acute or recent infection, including women of child-bearing age; recommended for use with Toxoplasma gondii IgG assay and not cleared for blood, plasma, or tissue donor screening.",
    "fda_folder": "Microbiology"
}